In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
Statins are lipid-lowering therapeutics with favorable anti-inflammatory profiles and have been proposed as an adjunct therapy for COVID-19. However, statins may increase the risk of SARS-CoV-2 viral entry by inducing ACE2 expression. Here, we performed a retrospective study on 13,981 patients with...
Saved in:
Published in | Cell metabolism Vol. 32; no. 2; pp. 176 - 187.e4 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
04.08.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!